Search Results - Prerna Arora
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
Examining the initial usability, acceptability and feasibility of a digital mental health intervention for college students in India by Nitya Kanuri, Prerna Arora, Sai Talluru, Bona Colaco, Rohan Dutta, Abhimanyu Rawat, C. Barr Taylor, M. Manjula, Michelle G. Newman
Published 2019Artigo -
5
-
6
-
7
-
8
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5 by Markus Hoffmann, Prerna Arora, Inga Nehlmeier, Amy Kempf, Anne Cossmann, Sebastian Schulz, Gema Morillas Ramos, Luis A. Manthey, Hans‐Martin Jäck, Georg Behrens, Stefan Pöhlmann
Published 2023Carta -
9
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage by Inga Nehlmeier, Amy Kempf, Prerna Arora, Anne Cossmann, Alexandra Dopfer‐Jablonka, Metodi V. Stankov, Sebastian Schulz, Hans‐Martin Jäck, Georg Behrens, Stefan Pöhlmann, Markus Hoffmann
Published 2023Carta -
10
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D by Prerna Arora, Lu Zhang, Inga Nehlmeier, Amy Kempf, Luise Graichen, Eike Kreitz, Anzhalika Sidarovich, Cheila Rocha, Sabine Gärtner, Michael Winkler, Sebastian Schulz, Hans‐Martin Jäck, Markus Hoffmann, Stefan Pöhlmann
Published 2025Artigo -
11
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy by Markus Hoffmann, Anzhalika Sidarovich, Prerna Arora, Nadine Krüger, Inga Nehlmeier, Amy Kempf, Luise Graichen, Martin Sebastian Winkler, Daniela Niemeyer, Christine Goffinet, Christian Drosten, Sebastian Schulz, Hans‐Martin Jäck, Stefan Pöhlmann
Published 2022Artigo -
12
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency by Prerna Arora, Cheila Rocha, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin Sebastian Winkler, Martin Lier, Sebastian Schulz, Hans‐Martin Jäck, Anne Cossmann, Metodi V. Stankov, Georg Behrens, Stefan Pöhlmann, Markus Hoffmann
Published 2021Artigo -
13
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination by Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, Anna-Sophie Moldenhauer, Martin Sebastian Winkler, Sebastian Schulz, Hans‐Martin Jäck, Metodi V. Stankov, Georg Behrens, Stefan Pöhlmann, Markus Hoffmann
Published 2021Artigo -
14
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies by Prerna Arora, Lu Zhang, Nadine Krüger, Cheila Rocha, Anzhalika Sidarovich, Sebastian Schulz, Amy Kempf, Luise Graichen, Anna-Sophie Moldenhauer, Anne Cossmann, Alexandra Dopfer‐Jablonka, Georg Behrens, Hans‐Martin Jäck, Stefan Pöhlmann, Markus Hoffmann
Published 2022Artigo -
15
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination by Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, Prerna Arora, Anzhalika Sidarovich, Anna-Sophie Moldenhauer, Martin Sebastian Winkler, Sebastian Schulz, Hans‐Martin Jäck, Metodi V. Stankov, Georg Behrens, Stefan Pöhlmann
Published 2021Artigo -
16
Omicron subvariant BA.5 efficiently infects lung cells by Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, Lu Zhang, Cheila Rocha, Abby Odle, Inga Nehlmeier, Amy Kempf, Anja Richter, Nico Joël Halwe, Jacob Schön, Lorenz Ulrich, Donata Hoffmann, Martin Beer, Christian Drosten, Stanley Perlman, Stefan Pöhlmann
Published 2023Artigo -
17
School Psychology Unified Antiracism Statement and Call to Action by Enedina García‐Vázquez, Linda A. Reddy, Prerna Arora, Franci Crepeau‐Hobson, Pamela Fenning, Clifford Hatt, Tammy L. Hughes, Shane R. Jimerson, Celeste M. Malone, Kathleen M. Minke, Kisha M. Radliff, Tara C. Raines, Sam Song, Kelly Vaillancourt Strobach
Published 2020Artigo -
18
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 by Prerna Arora, Lu Zhang, Cheila Rocha, Anzhalika Sidarovich, Amy Kempf, Sebastian Schulz, Anne Cossmann, Bernhard Manger, Eva Baier, Björn Tampe, Onnen Moerer, Steffen Dickel, Alexandra Dopfer‐Jablonka, Hans‐Martin Jäck, Georg Behrens, Martin Sebastian Winkler, Stefan Pöhlmann, Markus Hoffmann
Published 2022Carta -
19
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies by Markus Hoffmann, Prerna Arora, Rüdiger Groß, Alina Seidel, Bojan F. Hörnich, Alexander S. Hahn, Nadine Krüger, Luise Graichen, Heike Hofmann-Winkler, Amy Kempf, Martin Sebastian Winkler, Sebastian Schulz, Hans‐Martin Jäck, Bernd Jahrsdörfer, Hubert Schrezenmeier, Martin Müller, Alexander Kleger, Jan Münch, Stefan Pöhlmann
Published 2021Artigo -
20
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity by Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith, Nadine Krüger, Prerna Arora, Lambert K. Sørensen, Ole S. Søgaard, Jørgen B. Hasselstrøm, Michael Winkler, Tim Hempel, Lluı́s Raich, Simon Olsson, Olga Danov, Danny Jonigk, Takashi Yamazoe, Katsura Yamatsuta, Hirotaka Mizuno, Stephan Ludwig, Frank Noé, Mads Kjølby, Armin Braun, Jason M. Sheltzer, Stefan Pöhlmann
Published 2021Artigo
Search Tools:
Related Subjects
Virology
Medicine
Biology
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Genetics
Immunology
Outbreak
Virus
Antibody
Neutralization
Pathology
Gene
Internal medicine
Immune system
Pandemic
Vaccination
Computer science
Coronavirus
Lineage (genetic)
Psychology
Viral replication
Applied psychology
B cell
Booster (rocketry)
Business
Computational biology